Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Dichlorotetra-μ-Isobutyratodirhenium(III): Enhancement of Cisplatin Action and RBC-stabilizing Properties

NATALIA SHTEMENKO, PHILIPPE COLLERY and ALEXANDER SHTEMENKO
Anticancer Research July 2007, 27 (4B) 2487-2492;
NATALIA SHTEMENKO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ashtemenko{at}yahoo.com
PHILIPPE COLLERY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDER SHTEMENKO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 4B 2487-2492
PMID 
17695543

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 11, 2007
  • Revision received March 28, 2007
  • Accepted April 5, 2007
  • Published online July 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. NATALIA SHTEMENKO1,
  2. PHILIPPE COLLERY2 and
  3. ALEXANDER SHTEMENKO3
  1. 1Dnepropetrovsk National University, Dnepropetrovsk, Ukraine
  2. 2Service de Cancérologie, Polyclinique Maymard, Bastia, France;
  3. 3Ukrainian State Chemical Technological University, Dnepropetrovsk, Ukraine
  1. Correspondence to: Natalia Shtemenko I., 149/28 Gagarin Avenue, 49107 Dnepropetrovsk, Ukraine. Tel: +38 0567766179 / +38 0505896373, e-mail: ashtemenko{at}yahoo.com

Statistics from Altmetric.com

Cited By...

  • 45 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 4B
July-August 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dichlorotetra-μ-Isobutyratodirhenium(III): Enhancement of Cisplatin Action and RBC-stabilizing Properties
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Dichlorotetra-μ-Isobutyratodirhenium(III): Enhancement of Cisplatin Action and RBC-stabilizing Properties
NATALIA SHTEMENKO, PHILIPPE COLLERY, ALEXANDER SHTEMENKO
Anticancer Research Jul 2007, 27 (4B) 2487-2492;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Dichlorotetra-μ-Isobutyratodirhenium(III): Enhancement of Cisplatin Action and RBC-stabilizing Properties
NATALIA SHTEMENKO, PHILIPPE COLLERY, ALEXANDER SHTEMENKO
Anticancer Research Jul 2007, 27 (4B) 2487-2492;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Dose Effect of Rhenium (I)-diselenoether as Anticancer Drug in Resistant Breast Tumor-bearing Mice After Repeated Administrations
  • Uptake and Efflux of Rhenium in Cells Exposed to Rhenium Diseleno-Ether and Tissue Distribution of Rhenium and Selenium After Rhenium Diseleno-Ether Treatment in Mice
  • Combination of Three Metals for the Treatment of Cancer: Gallium, Rhenium and Platinum. 1. Determination of the Optimal Schedule of Treatment
  • Google Scholar

More in this TOC Section

  • Invasive-Front P21 Expression Is Associated With Tumor Aggressiveness in Head and Neck Squamous Cell Carcinoma
  • Isolation and Biological Evaluation of Breast Cancer Side Population Cells Using DyeCycle Violet
  • Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire